C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 3, 2002, Pages 1007-1013

  Barrett, Terrance D ^a   Hennan, James K ^a   Marks, Rory M ^b   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Department of Internal Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBON DIOXIDE; CROTON OIL; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RABBIT; REPERFUSION; RISK; TIME;

EID: 0036896917     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.040600     Document Type: Article

References (40)

1. Anderson HC and McCarty M (1951) The occurrence in the rabbit of an acute phase protein analogous to human C-reactive protein. J Exp Med 93:25-36.
2. Beranek JT (1997) C-Reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur Heart J 18:1834-1836.
3. Black SC, Gralinski MR, Friedrichs GS, Kilgore KS, Driscoll EM, and Lucchesi BR (1995) Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res 29:629-636.
4. Carr SC, Farb A, Pearce WH, Virmani R, and Yao JS (1997) Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122:757-763.
5. de Beer FC, Baltz ML, Munn EA, Feinstein A, Taylor J, Buton C, Clamp JR, and Pepys MB (1982) Isolation and characterisation of C-reactive protein and serum amyloid P component in the rat. Immunology 45:55-70.
6. du Clos TW (2000) Function of C-reactive protein. Ann Med 32:274-278.
7. du Clos TW, Mold C, Paterson PY, Alroy J, and Gewurz H (1981) Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin Exp Immunol 43:565-573.
8. Friedrichs GS, Kilgore KS, Manley PJ, Gralinski MR, and Lucchesi BR (1994) Effects of heparin and N-acetylheparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res 75:701-710.
9. Gabay C and Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454.
10. Gotschlich E and Stetson CA Jr (1960) Immunologic cross-reactions among mammalian acute hase proteins. J Exp Med 111:141-451.
11. Gralinski MR, Wiater BC, Assenmacher AN, and Lucchesi BR (1996) Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. Immunopharmacology 34:79-88.
12. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, and Pepys MB (1999) C-Reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190:1733-1740.
13. Heuertz RM, Piquette CA, and Webster RO (1993) Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Path 142:319-328.
14. Jolly SR, Kane WJ, Bailie MB, Abrams GD, and Lucchesi BR (1984) Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54:277-285.
15. Kilgore KS, Friedrichs GS, Homeister JW, and Lucchesi BR (1994) The complement system in myocardial ischaemia/reperfusion injury. Cardiovasc Res 28:437-444.
16. Kushner I, Broder ML, and Karp D (1978) Control of the acute pase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61:235-242.
17. Kushner I, Rakita I, and Kaplan MR (1963) Studies of the acute-phase protein. II: localization of Cx-protein in heart induced by myocardial infarction in rabbits. J Clin Invest 42:286-292.
18. Kushner I and Rzewnicki D (1999) Acute phase response, in Inflammation: Basic Principles and Clinical Correlates, 3rd Ed (Gallin JI and Snyderman R eds) pp 317-329, Lippincott, Williams & Wilkins, Philadelphia.
19. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, Verheugt FW, Meijer CJ, and Hack CE (1997) C-Reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95:97-103.
20. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, and Hack CE (1999) C-Reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100:96-102.
21. Lindahl B, Toss H, Siegbahn A, Venge P, and Wallentin L (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 343:1139-1147.
22. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, and Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417-424.
23. Mathey D, Schofer J, Schafer HJ, Hamdoch T, Joachim HC, Ritgen A, Hugo F, and Bhakdi S (1994) Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J 15:418-423.
24. Mortensen RF and Zhong W (2000) Regulation of phagocytic leukocyte activities by C-reactive protein. J Leukoc Biol 67:495-500.
25. Pasceri V, Willerson JT, and Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168.
26. Pepys MB (1981) C-Reactive protein fifty years on. Lancet 1:653-657.
27. Pepys MB and Baltz ML (1983) Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxin) and serum amyloid A protein. Adv Immunol 34:141-212.
28. Pietila KO, Harmoinen AP, Jokiniitty J, and Pasternack AI (1996) Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17:1345-1349.
29. Pinckard R, Olson MS, Giclas PC, Terry R, Boyer JT, and O'Rourke RA (1975) Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 56:740-750.
30. Ridker PM, Hennekens CH, Buring JE, and Rifai N (2000) C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843.
31. Ross R (1999) Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126.
32. Tanhehco EJ, Kilgore KS, Naylor KB, Park JL, Booth EA, and Lucchesi BR (1999) Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate. J Cardiovasc Pharmacol 34:153-161.
33. Van der Vusse GJ, van Bilsen M, and Reneman RS (1994) Ischemia and reperfusion induced alterations in membrane phospholipids: An overview. Ann NY Acad Sci 732:1-14.
34. Volanakis JE (1982) Complement activation by C-reactive protein complexes. Ann NY Acad Sci 389:235-274.
35. Westhuyzen J and Healy R (2000) Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 30:133-143.
36. Whaley K and North J (1997) Haemolytic assays for whole complement activity and individual components, in Complement. A Practical Approach (Dodds AW and Sim B eds) pp 19-47, Oxford University Press, New York.
37. Williams RC, Kilpatrick KA, Kassaby M, and Abdin ZH (1978) Lymphocytes binding C-reactive protein during acute rheumatic fever. J Clin Invest 61:1384-1393.
38. Yasojima K, Kilgore KS, Washington RA, Lucchesi BR, and McGeer PL (1998a) Complement gene expression by rabbit heart: Up-regulation by ischemia and reperfusion. Circ Res 82:1224-1230.
39. Yasojima K, Schwab C, McGeer EG, and McGeer PL (1998b) Human heart generates complement proteins that are unregulated and activated after myocardial infarction. Circ Res 83:860-869.
40. Yeh ET, Anderson HV, Pasceri V, and Willerson JT (2001) C-Reactive protein: Linking inflammation to cardiovascular complications. Circulation 104:974-975.